Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Add abstracts to 28 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact28 DOIs

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs

Attach ORCID iDs across 2 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 28 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Effect of loperamide on heart rhythm: Randomized, double-bli… (10.1016/j.japhar.2024.100006)	Abstract	17.47	4
2	Proportion of intensive care unit patients receiving sedatio… (10.1016/j.japhar.2024.100007)	Abstract	11.93	2
3	Effect of combination antibiotic therapy on clinical failure… (10.1016/j.japhar.2023.100001)	Abstract	7.53	1
4	Changes in serum potassium with concomitant administration o… (10.1016/j.japhar.2023.100002)	Abstract	7.53	1
5	Does phenobarbital reduce the hospital length of stay for pa… (10.1016/j.japhar.2023.100003)	Abstract	7.53	1
6	Advances in recognizing, treating, and preventing mpox infec… (10.1016/j.japhar.2023.100004)	Abstract	7.53	1
7	Guidance on calculating doses of antineoplastic agents for t… (10.1016/j.japhar.2024.100009)	Abstract	7.53	1
8	Alignment of counseling around topical steroids will improve… (10.1016/j.japhar.2025.100010)	Abstract	7.53	1
9	Safety of prolonged thrice-weekly high-dose daptomycin in a… (10.1016/j.japhar.2024.100008)	Abstract	0.00	0
10	Overall survival of patients over 65 years old with lung can… (10.1016/j.japhar.2025.100012)	Abstract	0.00	0
11	Real-world safety profile of lecanemab: A disproportionality… (10.1016/j.japhar.2025.100015)	Abstract	0.00	0
12	Evaluating the safety of daptomycin coadministered with stat… (10.1016/j.japhar.2025.100017)	Abstract	0.00	0
13	Nutrition support team impact on critically ill patients rec… (10.1016/j.japhar.2025.100018)	Abstract	0.00	0
14	Comparing intraoperative administration of long-acting bupiv… (10.1016/j.japhar.2025.100019)	Abstract	0.00	0
15	Impact of glucagon-like peptide-1 receptor agonist or glucag… (10.1016/j.japhar.2025.100020)	Abstract	0.00	0
16	Impact of obesogenic medications on weight loss potential wi… (10.1016/j.japhar.2025.100022)	Abstract References	0.00	0
17	Evaluation of the use of dyes at a tertiary academic medical… (10.1016/j.japhar.2025.100023)	Abstract	0.00	0
18	Adherence in initiators of combination therapy among drug-na… (10.1016/j.japhar.2025.100024)	Abstract	0.00	0
19	Medication adherence after transition to emicizumab in patie… (10.1016/j.japhar.2025.100025)	Abstract	0.00	0
20	Leveraging real-world data to create vancomycin population p… (10.1016/j.japhar.2025.100026)	Abstract	0.00	0
21	Disparities in sodium-glucose cotransporter-2 inhibitor usag… (10.1016/j.japhar.2026.100027)	Abstract	0.00	0
22	Risk of bradycardia and syncope associated with the use of c… (10.1016/j.japhar.2026.100028)	Abstract	0.00	0
23	Comparison of Forteo and PF708 teriparatide on improvements… (10.1016/j.japhar.2026.100029)	Abstract	0.00	0
24	Honoring our authors and peer reviewers (10.1016/j.japhar.2026.100030)	Abstract References ORCID	0.00	0
25	Journal of the American Pharmacists Association reviewers—20… (10.1016/j.japhar.2026.100031)	Abstract References ORCID	0.00	0
26	Beyond glucagon-like peptide-1: The promise of polyagonists… (10.1016/j.japhar.2026.100032)	Abstract	0.00	0
27	SGLT2 inhibitor-associated diabetic ketoacidosis in the inte… (10.1016/j.japhar.2026.100033)	Abstract References	0.00	0
28	Quetiapine for pediatric delirium in critically ill children… (10.1016/j.japhar.2026.100034)	Abstract References	0.00	0